KFDA to give fast-track approval for human influenza A vaccine

Published: 2009-05-21 06:59:00

Updated: 2009-05-21 06:59:00

A human vaccine against H1N1 Influenza A, which were reportedly developed by a local scientist, will get a quick approval as part of a move boost the number of doses for sale, according to the Korea Food and Drug Administration.

The drug agency said any new vaccine will have to clear at least ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK